受体相互作用蛋白激酶3在心血管疾病中的病理生理学作用
Jingjing Zhang1, Jianan Qian2, Wei Zhang3
1School of Medicine, Nantong University, Nantong, Jiangsu 226001, China.
概括
受体相互作用蛋白激酶3 (RIPK3) 通过影响CaMK II和线粒体孔隙驱动心肌亡. 抑制RIPK3显示出治疗心血管疾病的前景.
科学领域:
- 心血管生物学 心血管生物学
- 细胞死亡机制 细胞死亡机制
- 分子心脏病学分子心脏病学
背景情况:
- 受体相互作用蛋白激酶3 (RIPK3) 涉及到亡,一种编程细胞死亡的形式.
- RIPK3调解CaMK II酸化/氧化,打开线粒体透性过渡孔 (mPTP),并诱导心肌亡.
- 人们越来越认识到亡因其在心血管疾病发病过程中的作用.
研究的目的:
- 审查目前对RIPK3在亡,炎症和氧化应激中的作用的理解.
- 讨论RIPK3在各种心血管疾病中的参与.
- 突出RIPK3作为潜在的心血管疾病治疗点.
主要方法:
- 对研究RIPK3功能及其在心血管疾病中的作用的文献综述.
- 对将 RIPK3 与 CaMK II 联系起来的分子机制,mPTP 开放和亡的分析.
- 在心血管疾病的临床前模型中检查RIPK3抑制的证据.
主要成果:
- 增加RIPK3表达或酸化是死的关键标志物.
- 抑制CaMK II酸化/氧化显著降低了RIPK3介导的心肌亡.
- RIPK3抑制剂GSK872有效地抑制心血管疾病的进展,并逆转相关的心脏功能障碍.
结论:
- RIPK3是肌肉性心脏亡的关键调解者,在心血管疾病中起着重要作用.
- 针对RIPK3,例如GSK872,为心血管疾病提供了潜在的治疗策略.
- 对RIPK3功能的进一步研究可能会揭示治疗动脉样硬化,心肌缺血,心脏病发作和心力衰竭等疾病的新途径.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K


